We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Iowa Senator Calls for Clarity on Medicare Misclassification of Mylan’s EpiPen
Iowa Senator Calls for Clarity on Medicare Misclassification of Mylan’s EpiPen
Sen. Charles Grassley (R-Iowa) is pressing Mylan and the Centers for Medicare and Medicaid Services for answers on the misclassification of the company’s EpiPen as a generic for the agency’s drug rebate program.